Second Genome, Inc.

Karim Dabbagh

Andrew Wonhee Han

Todd Zachary DeSantis

Andrew Whitman Goodyear

Tarunmeet Gujral

Toshihiko Takeuchi

Ye Jin

Michi Izumi Willcoxon

Stefanie Banas

Bernat Baeza Raja

Mitsuko Lynn Yamamoto

Todd Zachary Desantis

Shoko Kawana

The disclosure relates to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointestinal inflammatory diseases and gastrointestinal conditions associated with decreased epithelial cell barrier function or integrity. Further, the disclosed therapeutic proteins are useful for treating human inflammatory bowel disease, including inter alia, Crohn's disease and ulcerative colitis.

Proteins for the treatment of epithelial barrier function disorders

The disclosure relates to live biotherapeutic products, probiotics, pharmaceutical compositions comprising said probiotics, and methods of using them to treat various human diseases. In some aspects, the disclosure provides such compositions comprising strains of the bacteriumand their uses in treating metabolic-related diseases or disorder.

as a biotherapeutic

Growing community of inventors

South San Francisco, CA, United States of America

Karim Dabbagh